The risk that Novartis will fail to realize a return on the buyout has intensified investor scrutiny of leadershipās M&A strategy. Successive Novartis chairs have failed on acquisitions, and the company must change how it oversees deals, David Samra, managing director at Artisan Partners, told Reuters. Artisan is a major shareholder in Novartis.
FBI Reform - fbireform.comFBI Reform - fbireform.com - The News And Times